Global Interleukin Inhibitors Market Size, Share and Forecast 2021-2027
The global Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 11.2% over the forecast period (2021-2027). The global Interleukin Inhibitors market is segmented on the basis of product type and applications. Based on the product type, the market is segmented as IL-1 inhibitors, IL-5 inhibitors, IL-6 inhibitors, IL-17 inhibitors, and IL-23 inhibitors. The IL-17 inhibitors segment is likely to register a significant market value over the forecast period. The key aspect that drives the growth of the global Interleukin Inhibitors market is the higher adoption of IL-17 inhibitors for the treatment of various skin diseases such as psoriasis. The IL-17 inhibitors function as angiogenesis; have a pro-inflammatory role in asthma; increases the inflammatory cytokines; and induces production of IL-4, IL-5, and IL-13, which stimulate eosinophil expansion.
To Request a Sample of our Report on Global Interleukin Inhibitors Market: https://www.omrglobal.com/request-sample/interleukin-inhibitors-market
Based on the applications, the market is segmented as arthritis, asthma,
eczema, inflammatory bowel disease (IBD), psoriasis, and others. The psoriasis
segment is likely to register a significant market value over the forecast
period. The key aspect that drives the segmental growth of the global
Interleukin Inhibitors market is the rising prevalence of psoriasis among
people across the globe. According to the World Psoriasis Day consortium,
globally 125 million people, that is, more than 3% of the total population
suffer from psoriasis. Further, the clinical trials going on regarding the
psoriasis treatment also creates scope for the market. As per the National
Clinical Trial (NCT) Registry, more than 200 clinical trials were going on, as
of December 2020, regarding the interleukin inhibitors in the US across
different phases of development for various indications including
psoriasis.
·
Market
number available for – 2020-2027
·
Base
year- 2020
·
Forecast
period- 2021-2027
·
Segment
Covered- By Product Type and Applications
·
Regions
Covered- North America, Europe, Asia-Pacific, Rest of the World
·
Competitive
Landscape- Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc,
Johnson and Johnson Services Inc., Merck KgaA, AstraZeneca Plc, and Sun
Pharmaceutical Industries Ltd. among others
(Get 15% Discount on Buying this Report)
A
full Report of Global Interleukin Inhibitors Market is Available
at: https://www.omrglobal.com/industry-reports/interleukin-inhibitors-market
Key questions
addressed by the report
·
What is
the market growth rate?
·
Which
segment/region dominates the market in base year?
·
Which
segment/region will project fastest growth in the market?
·
How
COVID-19 impacted the market?
Ø
Recovery
Timeline
Ø
Deviation
from pre-COVID forecast
Ø
Most affected
region/segment
·
Who is
the leader in the market?
·
How
players are addressing challenges to sustain growth?
·
Where
is the investment opportunity?
Global
Interleukin Inhibitors Market – Segmentation
By Product
Type
·
IL-1
Inhibitors
·
IL-5
Inhibitors
·
IL-6
Inhibitors
·
IL-17
Inhibitors
·
IL-23
Inhibitors
By
Applications
·
Arthritis
·
Asthma
·
Eczema
·
Inflammatory
Bowel Disease (IBD)
·
Psoriasis
·
Others
Global
Interleukin Inhibitors Market – Segmentation by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
Company Profiles
·
AbbVie,
Inc.
·
AstraZeneca
Plc
·
Bausch
Health Co. Inc.
·
Bristol–Myers
Squibb Co.
·
Regeneron
Pharmaceuticals, Inc.
·
Sanofi
SA
·
Sun
Pharmaceutical Industries Ltd.
·
Teva
Pharmaceuticals Industries, Ltd
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid data
sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/interleukin-inhibitors-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment